$PPCH HOD close at .0575. Let's hope this hits .10 by Friday. With NY Times news coupled and maybe even serving the dual purpose of FDA approval, this could move ten times, even from a pivot at .10. I bought in at .0274 and almost never buy anything out of sub-penny or triple-zero range. Something told me that this was a good one. The staff and scientists at Propanc have the right backgrounds and give the right 'feel'. The treatment(s) they are using and the reasons for using it (cancer metastases) give investors all the more reason to give this a second glance, even those of us who have purchased prior. Congrats to all on a nice close at HOD and to all making money. My only regret is not getting in with some of you at .004. Hats off to the savvy ones.